Patritumab (U3-1287)

patritumab · Daiichi Sankyo

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Patritumab (U3-1287), covering 2014-05-14 to 2014-05-14. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess Pharmacokinetics, Immunogenicity and Safety/Tolerability of Patritumab (U3-1287) [Phase 1]